For the latest period, Johnson & Johnson has a gross margin of 67.6%, an operating margin of 24.9%, an EBITDA margin of 27%, and a net margin of 16.2%. The company's available margins all deteriorated, with EBITDA margin reporting the strongest contraction of 16.2 percentage points.
Johnson & Johnson's margins averaged 68.4% gross, 25.03% operating, 40.53% EBITDA, and 27.28% net during the last 3 years. Compared with their three-year averages, all four current margins are lower.
Year over year, gross, operating, EBITDA, and net margins all declined, with EBITDA margin showing the largest decrease at 16.2 percentage points.
Over the last 3 years, Johnson & Johnson's gross margin averaged 68.4%. The current gross margin of 67.6% is 0.8 percentage points below its three-year average. During this period, gross margin reached a high of 69.2% in Mar 2024 and a low of 67.6% in Sep 2026.
The average operating margin for Johnson & Johnson was 25.03% during the last 3 years. At present, the current operating margin for Johnson & Johnson is 24.9%, 0.1 percentage points below its three-year average. The operating margin for Johnson & Johnson moved between 23.4% in Dec 2024 and 26.8% in Dec 2025.
The average EBITDA margin for Johnson & Johnson was 40.53% during the last 3 years. Johnson & Johnson currently reports an EBITDA margin of 27%, 13.5 percentage points below its three-year average. The EBITDA margin for Johnson & Johnson moved between 27% in Sep 2026 and 57.9% in Mar 2024.
Johnson & Johnson's net margin averaged 27.28% during the last 3 years. Compared with its three-year average, Johnson & Johnson's current net margin is 16.2% and is 11.1 percentage points below its three-year average. Over the last 3 years, Johnson & Johnson's net margin peaked at 44.9% in Mar 2024 and reached a low of 15.8% in Dec 2024.
Johnson & Johnson's gross margin of 67.6% is below the Healthcare sector, the industry and its peers average. But in comparison with its Healthcare sector average of 68.3%, Johnson & Johnson's gross margin is only 1% lower.
For the period ending Sep 27, 2026, JNJ recorded a gross margin of 67.6%.
The current operating margin for JNJ is 24.9% as of Sep 27, 2026.
As of Sep 27, 2026, JNJ has an EBITDA margin of 27%.
For the period ending Sep 27, 2026, JNJ recorded a net margin of 16.2%.
Johnson & Johnson's gross, operating, EBITDA, and net margins averaged 68.4% gross, 25.0% operating, 40.5% EBITDA, and 27.3% net over the last 3 years.
In the last 5 years, the highest margins reported by JNJ were 70.3% gross in Oct 2023, 26.8% operating in Dec 2025, 58% EBITDA in Oct 2023, and 45.4% net in Oct 2023.
Over the last 5 years, Johnson & Johnson's lowest margins were 67.6% gross in Sep 2026, 23.4% operating in Jul 2022, 27% EBITDA in Sep 2026, and 15.8% net in Dec 2024.